Thu, June 28, 2018
Wed, June 27, 2018
Tue, June 26, 2018
Mon, June 25, 2018
Fri, June 22, 2018

Adam Walsh Initiated (ASND) at Strong Buy and Held Target at $85 on, Jun 26th, 2018

Adam Walsh of Stifel, Initiated "Ascendis Pharma A/S" (ASND) at Strong Buy and Held Target at $85 on, Jun 26th, 2018.

Adam has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Adam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Adam


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $78 on, Tuesday, March 20th, 2018